vs
礼蓝动物保健（ELAN）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
ROKU, INC的季度营收约是礼蓝动物保健的1.2倍（$1.4B vs $1.1B），ROKU, INC净利率更高（5.8% vs -24.1%，领先29.9%），ROKU, INC同比增速更快（16.1% vs 12.2%），ROKU, INC自由现金流更多（$106.6M vs $46.0M），过去两年ROKU, INC的营收复合增速更高（25.8% vs -2.6%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
ELAN vs ROKU — 直观对比
营收规模更大
ROKU
是对方的1.2倍
$1.1B
营收增速更快
ROKU
高出4.0%
12.2%
净利率更高
ROKU
高出29.9%
-24.1%
自由现金流更多
ROKU
多$60.6M
$46.0M
两年增速更快
ROKU
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.4B |
| 净利润 | $-276.0M | $80.5M |
| 毛利率 | 51.5% | 43.5% |
| 营业利润率 | -22.6% | 4.7% |
| 净利率 | -24.1% | 5.8% |
| 营收同比 | 12.2% | 16.1% |
| 净利润同比 | -3350.0% | 326.4% |
| 每股收益（稀释后） | $-0.55 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANROKU
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.0B | $1.2B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $1.2B | $968.2M | ||
| Q1 24 | $1.2B | $881.5M |
净利润ELANROKU
| Q4 25 | $-276.0M | $80.5M | ||
| Q3 25 | $-34.0M | $24.8M | ||
| Q2 25 | $11.0M | $10.5M | ||
| Q1 25 | $67.0M | $-27.4M | ||
| Q4 24 | $-8.0M | $-35.5M | ||
| Q3 24 | $364.0M | $-9.0M | ||
| Q2 24 | $-50.0M | $-34.0M | ||
| Q1 24 | $32.0M | $-50.9M |
毛利率ELANROKU
| Q4 25 | 51.5% | 43.5% | ||
| Q3 25 | 53.4% | 43.4% | ||
| Q2 25 | 57.5% | 44.8% | ||
| Q1 25 | 57.3% | 43.6% | ||
| Q4 24 | 50.9% | 42.7% | ||
| Q3 24 | 52.2% | 45.2% | ||
| Q2 24 | 58.2% | 43.9% | ||
| Q1 24 | 57.3% | 44.1% |
营业利润率ELANROKU
| Q4 25 | -22.6% | 4.7% | ||
| Q3 25 | -4.4% | 0.8% | ||
| Q2 25 | 2.0% | -2.1% | ||
| Q1 25 | 5.0% | -5.7% | ||
| Q4 24 | -5.0% | -3.3% | ||
| Q3 24 | 54.3% | -3.4% | ||
| Q2 24 | -2.7% | -7.4% | ||
| Q1 24 | 1.0% | -8.2% |
净利率ELANROKU
| Q4 25 | -24.1% | 5.8% | ||
| Q3 25 | -3.0% | 2.0% | ||
| Q2 25 | 0.9% | 0.9% | ||
| Q1 25 | 5.6% | -2.7% | ||
| Q4 24 | -0.8% | -3.0% | ||
| Q3 24 | 35.3% | -0.9% | ||
| Q2 24 | -4.2% | -3.5% | ||
| Q1 24 | 2.7% | -5.8% |
每股收益（稀释后）ELANROKU
| Q4 25 | $-0.55 | $0.55 | ||
| Q3 25 | $-0.07 | $0.16 | ||
| Q2 25 | $0.02 | $0.07 | ||
| Q1 25 | $0.13 | $-0.19 | ||
| Q4 24 | $-0.01 | $-0.24 | ||
| Q3 24 | $0.73 | $-0.06 | ||
| Q2 24 | $-0.10 | $-0.24 | ||
| Q1 24 | $0.06 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | $2.3B |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $6.5B | $2.7B |
| 总资产 | $13.4B | $4.4B |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势，按日历期对齐
现金及短期投资ELANROKU
| Q4 25 | $545.0M | $2.3B | ||
| Q3 25 | $505.0M | $2.3B | ||
| Q2 25 | $539.0M | $2.3B | ||
| Q1 25 | $487.0M | $2.3B | ||
| Q4 24 | $468.0M | $2.2B | ||
| Q3 24 | $490.0M | $2.1B | ||
| Q2 24 | $416.0M | $2.1B | ||
| Q1 24 | $345.0M | $2.1B |
总债务ELANROKU
| Q4 25 | $3.9B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.8B | — |
股东权益ELANROKU
| Q4 25 | $6.5B | $2.7B | ||
| Q3 25 | $6.7B | $2.6B | ||
| Q2 25 | $6.8B | $2.6B | ||
| Q1 25 | $6.4B | $2.5B | ||
| Q4 24 | $6.1B | $2.5B | ||
| Q3 24 | $6.5B | $2.5B | ||
| Q2 24 | $5.9B | $2.4B | ||
| Q1 24 | $6.1B | $2.4B |
总资产ELANROKU
| Q4 25 | $13.4B | $4.4B | ||
| Q3 25 | $13.6B | $4.4B | ||
| Q2 25 | $13.7B | $4.3B | ||
| Q1 25 | $12.9B | $4.2B | ||
| Q4 24 | $12.6B | $4.3B | ||
| Q3 24 | $13.3B | $4.3B | ||
| Q2 24 | $13.8B | $4.1B | ||
| Q1 24 | $14.0B | $4.2B |
负债/权益比ELANROKU
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.95× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | $107.7M |
| 自由现金流经营现金流 - 资本支出 | $46.0M | $106.6M |
| 自由现金流率自由现金流/营收 | 4.0% | 7.6% |
| 资本支出强度资本支出/营收 | 5.4% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 1.34× |
| 过去12个月自由现金流最近4个季度 | $284.0M | $478.4M |
8季度趋势，按日历期对齐
经营现金流ELANROKU
| Q4 25 | $108.0M | $107.7M | ||
| Q3 25 | $219.0M | $127.6M | ||
| Q2 25 | $237.0M | $109.7M | ||
| Q1 25 | $-4.0M | $138.7M | ||
| Q4 24 | $177.0M | $79.3M | ||
| Q3 24 | $162.0M | $68.7M | ||
| Q2 24 | $200.0M | $23.4M | ||
| Q1 24 | $2.0M | $46.7M |
自由现金流ELANROKU
| Q4 25 | $46.0M | $106.6M | ||
| Q3 25 | $127.0M | $126.5M | ||
| Q2 25 | $180.0M | $108.6M | ||
| Q1 25 | $-69.0M | $136.8M | ||
| Q4 24 | $130.0M | $76.8M | ||
| Q3 24 | $120.0M | $67.6M | ||
| Q2 24 | $166.0M | $22.5M | ||
| Q1 24 | $-22.0M | $46.0M |
自由现金流率ELANROKU
| Q4 25 | 4.0% | 7.6% | ||
| Q3 25 | 11.2% | 10.4% | ||
| Q2 25 | 14.5% | 9.8% | ||
| Q1 25 | -5.8% | 13.4% | ||
| Q4 24 | 12.7% | 6.4% | ||
| Q3 24 | 11.7% | 6.4% | ||
| Q2 24 | 14.0% | 2.3% | ||
| Q1 24 | -1.8% | 5.2% |
资本支出强度ELANROKU
| Q4 25 | 5.4% | 0.1% | ||
| Q3 25 | 8.1% | 0.1% | ||
| Q2 25 | 4.6% | 0.1% | ||
| Q1 25 | 5.4% | 0.2% | ||
| Q4 24 | 4.6% | 0.2% | ||
| Q3 24 | 4.1% | 0.1% | ||
| Q2 24 | 2.9% | 0.1% | ||
| Q1 24 | 2.0% | 0.1% |
现金转化率ELANROKU
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 5.14× | ||
| Q2 25 | 21.55× | 10.45× | ||
| Q1 25 | -0.06× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
ROKU
| Services | $1.2B | 88% |
| Products | $170.9M | 12% |
